Is a complete AIM/GENI research report available?

No complete published report is available for aim/GENI (AIM/GENI) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

AIM/GENI (AIM/GENI)

London Stock Exchange AIM: AIM/GENI · GBX

GBX 0.90

-0.05 (-5.3%)· Recorded snapshot

Market cap	7.2M
Revenue (ttm)	3.1M
Net income (ttm)	-5.7M
EPS (ttm)	-GBX 0.02
Shares out	753M
Volume	2,735,846
Beta	0.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.1M
Net income (ttm): -5.7M
EPS (ttm): -GBX 0.02
Market cap: 7.2M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All AIM/GENI indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

GBP

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	44
Employees Change	2%
Employees Change Percent	4.76
Enterprise value	GBX 6.5M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Medical - Diagnostics & Research
Isin	GB00BL97B504
Last refreshed	2026-09-11
Market cap	GBX 7.2M
Price	GBX 0.9
Price currency	GBX
Rev Per Employee	69,909.09x
Sector	Healthcare
Sector PE	21.2
Sector PE Fwd	13.53
Sic	8000
Symbol	aim/GENI
Website	https://www.genincode.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-79.75%
EV/Sales	2.1x
FCF yield	-58.26%
P/B ratio	57.69x
P/S ratio	2.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-191.58%
EBITDA Margin	-185.63%
Gross margin	58.65%
Gross Profit	GBX 1.8M
Gross Profit Growth	26.51%
Gross Profit Growth Q	37.21%
Gross Profit Growth3 Y	41.85%
Gross Profit Growth5 Y	28.1%
Net Income	GBX -5.7M
Net Income Growth Years	0%
Pretax Margin	-190.6%
Profit Margin	-185.47%
Profit Per Employee	GBX -129,659
ROA	-146.2
Roa5y	-69.84
ROCE	-3,329.4
ROE	-912.1
Roe5y	-307.3
ROIC	-451.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-35.73%
Cagr3y	-58.11%
Cagr5y	-53.64%
EPS Growth Quarters	4
EPS Growth Years	2
Revenue Growth	13.88x
Revenue Growth Q	12.35x
Revenue Growth Qo Q	-7.99x
Revenue Growth Quarters	10x
Revenue Growth Years	5x
Revenue Growth3 Y	29.09x
Revenue Growth5 Y	26.2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 1.22
Assets	GBX 2.4M
Cash	GBX 827,000
Current Assets	GBX 2M
Current Liabilities	GBX 2.2M
Debt	GBX 146,000
Debt Equity	GBX 1.18
Debt FCF	GBX -0.04
Equity	GBX 124,000
Interest Coverage	-453.3
Liabilities	GBX 2.3M
Long Term Assets	GBX 335,000
Long Term Liabilities	GBX 53,000
Net Cash	GBX 681,000
Net Cash By Market Cap	GBX 9.52
Net Cash Growth	-22.26%
Net Debt Equity	GBX -5.49
Tangible Book Value	GBX 26,000
Tangible Book Value Per Share	GBX 0
WACC	7.48

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.93
Inventory Turnover	12.78
Net Working Capital	GBX -890,000
Quick ratio	0.81
Working Capital	GBX -158,000
Working Capital Turnover	GBX 10.81

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-56.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-35.71%
200-day SMA	1.29
3Y total return	-92.65%
50-day SMA	0.88
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.86%
All Time High	48
All Time High Change	-98.13%
All Time High Date	2021-07-22
All Time Low	0.75
All Time Low Change	20%
All Time Low Date	2026-07-15
ATR	0.11
Beta	0.59
Beta1y	-0.59
Beta2y	-0.02
Ch YTD	-62.5
High	1
High52	5.5
High52 Date	2025-09-22
High52ch	-83.64%
Low	0.9
Low52	0.75
Low52 Date	2026-08-03
Low52ch	20%
Ma50ch	2.67%
Price vs 200-day SMA	-30.45%
RSI	53.25
RSI Monthly	34.64
RSI Weekly	42.89
Sharpe ratio	0.32x
Sharpe Ratio3y	-0.15x
Sharpe Ratio5y	-0.19x
Sortino ratio	0.87
Sortino Ratio3y	-0.25
Sortino Ratio5y	-0.38
Total Return	-56.75%
Tr YTD	-62.5
Tr1m	5.88%
Tr1w	-5.26%
Tr3m	-10%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	372,135,067%
Net Borrowing	-101,000
Shares Insiders	16.11%
Shares Institutions	45.04%
Shares Out	753,041,137
Shares Qo Q	20.34%
Shares Yo Y	56.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -4.9M
Adjusted OCF	-4,885,000
Average Volume	2,921,954.7x
Bv Per Share	0
CAPEX	GBX -44,000
Ch1m	5.88
Ch1w	-5.26
Ch1y	-35.71
Ch3m	-10
Ch3y	-92.65
Ch5y	-97.86
Ch6m	-18.18
Change	-5.26%
Change From Open	-3.23
Close	0.95
Days Gap	-2.11
Depreciation Amortization	183,000
Dollar Volume	2,462,261.4
Earnings Date	2026-09-24
EBIT	GBX -5.9M
EBITDA	GBX -5.7M
EPS	GBX -0.02
F Score	3
FCF	GBX -4.2M
FCF EV Yield	-64.39x
FCF Per Share	GBX -0.01
Financing CF	3,642,000
Fiscal Year End	December
Founded	2,018
Income Tax	GBX -158,000
Investing CF	-1,000
Is Primary Listing	1
Last Earnings Date	2026-06-08
Last Report Date	2025-12-31
Ma150	1.02
Ma150ch	-11.5%
Ma20	0.93
Ma20ch	-3.49%
Net CF	-283,000
Next Earnings Date	2026-09-24
Open	0.93
Position In Range	0
Ppne	237,000
Price Date	2026-09-10
Ptbv Ratio	275.1
Relative Volume	0.97x
Revenue	3,076,000x
SBC By Revenue	24.74x
Share Based Comp	761,000
Tax By Revenue	-5.14x
Tr6m	-18.18%
Volume	2,735,846
Z Score	-20.19

AIM/GENI (AIM/GENI)

Price

Financial snapshot

Fair-value bridge

Latest news · AIM/GENI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All AIM/GENI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on AIM/GENI

Frequently asked questions